Effects of substrate deprivation therapy on brain lipids in neonatal GML storage disease mice
Main Authors: | Kasperzyk, J, Hauser, E, D'Azzo, A, Platt, F, Seyfried, T |
---|---|
Format: | Conference item |
Published: |
2003
|
Similar Items
-
Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
by: Kasperzyk, J, et al.
Published: (2002) -
Therapeutic assessment of substrate deprivation using NB-DGJ in GM1 storage disease mice
by: Seyfried, T, et al.
Published: (2003) -
Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
by: Kasperzyk, J, et al.
Published: (2005) -
Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
by: Baek, R, et al.
Published: (2005) -
N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
by: Kasperzyk, J, et al.
Published: (2004)